MicuRx Pharmaceuticals, a Sino-US bio-pharmaceutical company, has received RMB100 million ($15.1 million) in funding in a round led by existing investors Delian Capital and BVCF.
The capital will support completion of phase-three clinical trials in China for MRX-1, an antibiotic that targets infections created by multi-drug resistant bacteria. This will be followed by new drug...
Singapore’s GIC Private and Sequoia Capital China have invested a combined $40 million in Korean financial technology company Viva Republica.
Japanese corporate pension funds are looking to increase their allocations to infrastructure, but they value the opportunity to visit managers before committing capital.
Nazrin Hassan, CEO of Cradle Fund, died on June 14 due to blast injuries incurred when his mobile phone exploded, the Malaysian venture capital firm has confirmed.